del nido cardioplegia ingredients, check these out | What type of cardioplegia is del Nido?
A single dose of del Nido cardioplegia contains 26 mEq/L of potassium chloride, 13 mL of 1% lidocaine, 3.2 g/L of 20% mannitol, 2 g of 50% magnesium sulfate, 13 mEq/L of sodium bicarbonate, and 1000 mL of Plasma-Lyte A. It is delivered 1:4 with oxygenated patient’s blood to crystalloid (8–10).
What type of cardioplegia is del Nido?
Del Nido cardioplegic solution (DNC), a blood-and-crystalloid solution, is used as a single-dose antegrade infusion to induce rapid cardiac arrest and provide at least 90 minutes of myocardial protection in neonatal heart surgery.
What is the composition of the cardioplegia solution used?
Each 100 mL of solution contains Calcium Chloride Dihydrate USP 17.6 mg, Magnesium Chloride, Hexahydrate USP 325.3 mg, Potassium Chloride USP 119.3 mg and Sodium Chloride USP 643 mg in Water for Injection, USP.
How does del Nido cardioplegia work?
Anaerobic glycolysis and its production of ATP has been shown to be inhibited by excess hydrogen ion accumulation (17,27,28). The del Nido cardioplegia mix incorporates sodium bicarbonate as a buffering solution to scavenge excess hydrogen ions and to assist in maintaining intracellular pH.
When should I Redose del Nido cardioplegia?
The DN protocol was to administer 1000 to 1200 ml as an initial dose and to add maintenance dose(s) (500 ml each) every 60 minutes when the estimated cross-clamp time was over 90 minutes. CWB was given every 20 minutes, regardless of cross-clamp time.
What is del Nido?
The crystalloid del Nido solution is given with 20% volume blood additive. The blood has its effect in supporting aerobic metabolism, providing buffering capabilities and improving coronary perfusion during the delivery [16].
What is del Nido solution?
A single dose of del Nido cardioplegia contains 26 mEq/L of potassium chloride, 13 mL of 1% lidocaine, 3.2 g/L of 20% mannitol, 2 g of 50% magnesium sulfate, 13 mEq/L of sodium bicarbonate, and 1000 mL of Plasma-Lyte A. It is delivered 1:4 with oxygenated patient’s blood to crystalloid (8–10).
What is cardioplegia solution?
Solution. Cardioplegia Solution A is a sterile, non-pyrogenic solution for cardiac perfusion in a Viaflex bag. It is used to induce cardiac stasis and to protect the myocardium during open-heart surgery.
How do you prepare a cardioplegia solution?
make the solution, add the following to 1 liter of dH 2 O while mixing using a magnetic stirrer: 0.99 g of glucose (5.50 mM), 0.13 g of magnesium sulfate (0.50 mM), 1.79 g of potassium chloride (24.00 mM), 1.68 g of sodium bicarbonate (20.00 mM), 6.37 g of sodium chloride (109.00 mM), 0.12 g of sodium phosphate
How do you prepare for cardioplegia?
[15] The initial dose of cardioplegia is typically cold, and when preparing to come off bypass and rewarming of the patient occurs, the surgeon may request a “hot-shot,” which is a dose of warm cardioplegia.
What is Microplegia?
Abstract. Background: Microplegia (whole blood cardioplegia with reduced volume) retains all the advantages of blood cardioplegia (such as superior oxygen-carrying capacity, better osmotic properties and antioxidant capability, etc.) without the potential disadvantages of hemodilution (such as myocardial edema).
What is Sondergaard’s groove?
Posterior and parallel to the terminal groove is a second, deeper groove between the right atrium and the right pulmonary veins. Dissections into this deep interatrial groove, also known as Waterston’s or Sondergaard’s groove, permit incisions to be made into the left atrium (Fig. 47-9).
What are cardioplegic drugs?
Cardioplegic Description. Baxter Cardioplegic Solution is a sterile, nonpyrogenic, essentially isotonic, formulation of electrolytes in Water for Injection, USP. It is a “core solution” intended for use only after addition of sodium bicarbonate to adjust pH prior to administration.
What is St Thomas cardioplegia?
Thomas’ Hospital cardioplegic solution number 2. This cardioplegic solution (NaCl 110.0 mM, NaHCO3 10.0 mM, KCl 16.0 mM, MgCl2 16.0 mM, CaCl2 1.2 mM, pH 7.8) is designed for routine clinical use combining optimal protection with simplicity of formulation and administration/infusion.
Who invented cardioplegia?
The term cardioplegia (cardio, heart and plegia, paralysis) was first introduced by Lam in 1957 (Lam et al., 1957), yet the method of arrest has its roots in the early experiments of British physiologist Sidney Ringer using the frog heart (Figure 2).
What is retrograde cardioplegia?
Retrograde cannulae are designed to deliver cardioplegia solution to the heart via the coronary sinus in the reverse direction of normal blood flow (retrograde perfusion). These cannulae are offered in either auto inflating or manual inflating cuff models.